Definium Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	19.96	273.74	99.7	142.14	133.54	80.09
Cash & Short-Term Investments	209.07	273.74	99.7	142.14	133.54	80.09
Cash Growth	-29.20%	174.55%	-29.86%	6.44%	66.73%	1094.90%
Prepaid Expenses	6.78	7.88	4.17	3.91	3.68	1.43
Total Current Assets	215.85	281.62	103.87	146.06	137.22	81.52
Goodwill	19.92	19.92	19.92	19.92	19.92	-
Other Intangible Assets	-	-	0.53	3.69	6.87	-
Other Long-Term Assets	0.55	0.61	0.22	0.33	-	-
Total Assets	236.92	302.15	124.54	169.99	164	81.52
Accounts Payable	8.11	2.01	4.14	2.11	4.18	2.02
Accrued Expenses	18.95	12.83	11.63	5.88	6.23	0.99
Other Current Liabilities	38.28	24.01	16.48	9.9	-	-
Total Current Liabilities	65.42	38.85	32.25	17.89	10.41	3.01
Long-Term Debt	40.39	21.85	14.13	-	-	-
Other Long-Term Liabilities	-	-	0.03	1.18	1.93	2.64
Total Liabilities	106.32	60.7	46.41	19.08	12.34	5.65
Additional Paid-In Capital	661.83	639.51	367.99	344.76	288.29	120.22
Retained Earnings	-532.24	-398.88	-290.2	-194.47	-137.67	-44.64
Comprehensive Income & Other	1	0.82	0.34	0.63	1.05	0.28
Shareholders' Equity	130.6	241.45	78.13	150.92	151.66	75.87
Total Liabilities & Equity	236.92	302.15	124.54	169.99	164	81.52
Total Debt	40.99	21.85	14.13	-	-	-
Net Cash (Debt)	168.09	251.89	85.58	142.14	133.54	80.09
Net Cash Growth	-37.97%	194.35%	-39.80%	6.44%	66.73%	1094.90%
Net Cash Per Share	1.98	3.57	2.19	4.61	4.88	4.51
Filing Date Shares Outstanding	98.51	75.37	41.33	38.06	28.58	75.41
Total Common Shares Outstanding	76.77	75.1	41.1	37.98	28.55	75.41
Working Capital	150.43	242.77	71.63	128.16	126.81	78.51
Book Value Per Share	1.70	3.21	1.90	3.97	5.31	1.01
Tangible Book Value	110.68	221.53	57.69	127.31	124.88	75.87
Tangible Book Value Per Share	1.44	2.95	1.40	3.35	4.37	1.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.